Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection (NCT04727788)
Validation of Genomic Immune-phenotyping Profiles in Peripheral Blood Gene Signatures to Predict Risk of Kidney Transplant Rejection
🩺 Plain-English Summary (8th-Grade Level)
Global, non-randomized, observational study for the validation of Verici Dx genomic tests to predict risk of kidney clinical and subclinical acute rejection, and chronic allograft damage or interstitial fibrosis / tubular atrophy by correlating peripheral blood gene expression profiles with graft injury (e.g. cellular / antibody-mediated), rejection and death censored graft loss.
Who can join: Review the eligibility criteria below.
Location: University of Illinois at Chicago — Chicago, Illinois
Age range: 18 Years to 80 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- University of Illinois at Chicago — Chicago, Illinois
- Northwestern University — Evanston, Illinois
- University of Maryland — Baltimore, Maryland
- Henry Ford — Detroit, Michigan
- University of Nebraska Medical Center — Omaha, Nebraska
- Cleveland Clinic — Cleveland, Ohio
- University of Pittsburgh — Pittsburgh, Pennsylvania
- Vanderbilt University Medical Center — Nashville, Tennessee
- University of Washington — Seattle, Washington
- CHU Grenoble Alpes Health Center — Grenoble,
- Bologna University — Bologna,
- Brescia University — Brescia,
- University Hospital Vall d'Hebron, Barcelona — Barcelona,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Kidney Transplant Rejection
- Microbiome and Immunosuppression: The Mission Study — Minneapolis, Minnesota
- The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) — Birmingham, Alabama
- PROACT Pilot Trial — Vancouver, British Columbia
- AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function — Gainesville, Florida
- Trifecta-Kidney cfDNA-MMDx Study — Tampa, Florida
Explore by condition: All Kidney Transplant Rejection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.